(Reuters) - Lupin Ltd, India's second-largest drugmaker by revenue, posted a 41.5 percent fall in second-quarter profit on Wednesday, hurt by higher expenses.

Net profit was 2.66 billion rupees ($36.00 million) in the quarter ended Sept. 30, compared with a profit of 4.55 billion rupees a year earlier, Lupin said.

Analysts on average had expected a profit of 2.73 billion rupees, according to Refintiv data.

Income from operations rose marginally to 38.91 billion rupees.

($1 = 73.8850 Indian rupees)

(Reporting by Tanvi Mehta in Bengaluru; Editing by Amrutha Gayathri)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)